Search Articles

View query in Help articles search

Search Results (1 to 8 of 8 Results)

Download search results: CSV END BibTex RIS


Correlation Between Serum and Urine Biomarkers and the Intensity of Acute Radiation Cystitis in Patients Treated With Radiation Therapy for Localized Prostate Cancer: Protocol for the Radiotoxicity Bladder Biomarkers (RABBIO) Study

Correlation Between Serum and Urine Biomarkers and the Intensity of Acute Radiation Cystitis in Patients Treated With Radiation Therapy for Localized Prostate Cancer: Protocol for the Radiotoxicity Bladder Biomarkers (RABBIO) Study

It has been shown that the urinary microbiota of patients with interstitial cystitis is less diverse than that of patients without these symptoms [20]. To date, no study has evaluated the modification of the urinary microbiota in patients with radiation cystitis. A better understanding of the impact of the urinary microbiota on the etiopathogenesis of urological disorders may help optimize medical management. It is also important to note that the microbiota of different organs are linked.

Carole Helissey, Sophie Cavallero, Stanislas Mondot, Charles Parnot, Halima Yssaad, Selma Becherirat, Nathalie Guitard, Hélène Thery, Antoine Schernberg, Hugo Breitwiller, Cyrus Chargari, Sabine Francois

JMIR Res Protoc 2023;12:e38362

Examining the Relationships Between Sleep Physiology and the Gut Microbiome in Preclinical and Translational Research: Protocol for a Scoping Review

Examining the Relationships Between Sleep Physiology and the Gut Microbiome in Preclinical and Translational Research: Protocol for a Scoping Review

The gut microbiota, or the community of bacteria in the gastrointestinal system, has been shown to display diurnal fluctuations in composition and function, which are both coordinated with host feeding time, the anticipation of nutrient digestion, and energy metabolism [35]. The human gut microbiome is characterized by the bacteria that occupy the digestive tracts of humans in combination with their collective genetic information [36].

Katherine Anne Maki, Jenna Alkhatib, Gisela Butera, Gwenyth Reid Wallen

JMIR Res Protoc 2022;11(6):e38605

Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial

Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial

The composition of gut microbiota differs between subgroups of IBS patients and healthy individuals [16]. This fact, together with an increasing awareness of the importance of a “healthy gut” and the gastrointestinal microbiome, has led to growing research, financial investment, and consumer interest in probiotic treatments that may provide benefits to patients with IBS [17,18].

Dorit Vedel Ankersen, Petra Weimers, Mette Bennedsen, Anne Birgitte Haaber, Eva Lund Fjordside, Moritz Emanuel Beber, Christian Lieven, Sanaz Saboori, Nicolai Vad, Terje Rannem, Dorte Marker, Kristine Paridaens, Suzanne Frahm, Lisbeth Jensen, Malte Rosager Hansen, Johan Burisch, Pia Munkholm

J Med Internet Res 2021;23(12):e30291

An Intervention With Michigan-Grown Wheat in Healthy Adult Humans to Determine Effect on Gut Microbiota: Protocol for a Crossover Trial

An Intervention With Michigan-Grown Wheat in Healthy Adult Humans to Determine Effect on Gut Microbiota: Protocol for a Crossover Trial

In this way, the gut microbiota can benefit the host, offering protection from pathogens and supporting immune regulation [2]. However, a dysbiotic gut microbiota is linked to disturbances in metabolic and biological processes, leading to a variety of chronic diseases as well as cancers [3]. Individuals with reduced bacterial richness are characterized by phenotypes such as increased adiposity and insulin resistance [3].

Gigi A Kinney, Eliot N Haddad, Linda S Garrow, Perry K W Ng, Sarah S Comstock

JMIR Res Protoc 2021;10(10):e29046

Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study

Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study

This study aims to investigate whether the gut and oral microbiota, or changes in gut and oral microbiota after therapy, are a predictor for treatment response in subjects with active relapsing-remitting MS (RRMS) and whether these changes result in downgrading the immune response. To our knowledge, this is the first study to investigate changes in microbiota and immune response in patients with RRMS in a longitudinal follow-up setting.

Jeske van Pamelen, Lynn van Olst, Andries E Budding, BIA Study Group, Helga E de Vries, Leo H Visser

JMIR Res Protoc 2020;9(7):e16162

Efficacy of a Green Banana–Mixed Diet in the Management of Persistent Diarrhea: Protocol for an Open-Labeled, Randomized Controlled Trial

Efficacy of a Green Banana–Mixed Diet in the Management of Persistent Diarrhea: Protocol for an Open-Labeled, Randomized Controlled Trial

The human body is home to trillions of microorganisms, primarily bacteria in the gut, which are generally referred to as the microbiota [28]. Commensal gut microbiota dysbiosis is increasingly recognized in the pathogenesis of PD [29]. Therefore, analysis of the commensal gut microbiota and adjusting the intestinal microbiota might be a promising method for the prevention or treatment of PD.

Monira Sarmin, Md Iqbal Hossain, Shoeb Bin Islam, Nur Haque Alam, Shafiqul Alam Sarker, M Munirul Islam, Mohammod Jobayer Chisti, S M Rafiqul Islam, Mustafa Mahfuz, Tahmeed Ahmed

JMIR Res Protoc 2020;9(3):e15759

Diet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study

Diet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study

For example, transplantation of gut microbiota from obese into germ-free mice has been shown to cause a higher fat mass increase than transplantation of lean microbiota. [3] Thus, altering gut bacterial composition can have a direct effect on body weight. In addition, gut microbiota might play a potential role in the treatment of T2 DM. Indeed, targeting gut microbiota by antibiotic treatment has been shown to improve body weight and glucose tolerance of high-fat fed mice [4,5].

Martine Uittenbogaart, Wouter KG Leclercq, Danielle Bonouvrie, Marleen M Romeijn, Arijan APM Luijten, Steven WM Olde Damink, Francois MH van Dielen, Sander S Rensen

JMIR Res Protoc 2019;8(6):e11553